Acute Coronary Syndrome: Core Definitions and Diagnostic Framework

Definition and Classification

The American College of Cardiology (ACC) defines acute coronary syndrome (ACS) as comprising three distinct clinical entities: unstable angina, non‑ST‑segment elevation myocardial infarction (NSTEMI), and ST‑segment elevation myocardial infarction (STEMI) 1, 2.
Unstable angina is characterized by transient myocardial ischemia with reduced coronary flow but without myocardial necrosis, distinguishing it from infarction 1, 2.
NSTEMI involves myocardial ischemia with necrosis, evidenced by cardiac troponin levels above the 99th percentile, yet lacks persistent ST‑segment elevation on the ECG 1, 2.
NSTEMI typically arises from a partially occluded coronary artery that produces subendocardial ischemia 1, 2.
STEMI is defined by myocardial ischemia with necrosis (elevated troponin) together with persistent ST‑segment elevation lasting more than 20 minutes on the ECG 3, 2.
STEMI results from a completely occluded coronary vessel causing transmural myocardial ischemia and infarction 1, 2.

Underlying Pathophysiology

All three ACS entities share a common mechanism: disruption of an atherosclerotic plaque (rupture or erosion) followed by partial or complete coronary thrombosis, leading to reduced myocardial blood flow 1, 2.
The extent of coronary artery occlusion determines the clinical presentation along the ACS spectrum, ranging from unstable angina (partial occlusion) to STEMI (complete occlusion) 1, 2.

Diagnostic Approach

The European Society of Cardiology (ESC) recommends obtaining a 12‑lead electrocardiogram within 10 minutes of patient presentation to differentiate STEMI from non‑ST‑elevation ACS (NSTE‑ACS) 3.
Persistent ST‑segment elevation on the initial ECG directs the patient to the STEMI pathway, prompting immediate reperfusion strategies 3.
Absence of persistent ST elevation places the patient in the NSTE‑ACS pathway, where high‑sensitivity cardiac troponin testing is required to separate unstable angina from NSTEMI 3.
A high‑sensitivity cardiac troponin (hs‑cTn) value above the 99th percentile upper reference limit, at least once, distinguishes NSTEMI from unstable angina 3.

Clinical Progression and Management Implications

The ACC notes that ACS is a dynamic process; patients may rapidly evolve from unstable angina to NSTEMI and then to STEMI during initial evaluation 1, 2.
A partially occlusive thrombus can extend to a complete occlusion, potentially converting an NSTEMI presentation into STEMI 1.

Classification within Universal MI Definition

All three ACS entities correspond to Type 1 myocardial infarction according to the Universal Definition of Myocardial Infarction, reflecting primary coronary atherothrombotic events 1, 2.
Less common etiologies such as coronary artery spasm, embolism, or dissection can mimic ACS clinically but require distinct management pathways 1, 2.

Acute Coronary Syndrome Diagnosis and Management

Clinical Presentation and Diagnosis

The American College of Cardiology and European Heart Journal recommend that the initial diagnosis of Acute Coronary Syndrome (ACS) should be based on clinical history and symptomatology, 12-lead electrocardiogram (ECG), and cardiac troponin assessment, with ACS encompassing three related clinical conditions: Unstable Angina (UA), Non-ST-Segment Elevation Myocardial Infarction (NSTEMI), and ST-Segment Elevation Myocardial Infarction (STEMI) 4, 5, 6, 7
A normal ECG does not exclude ACS, and many patients with NSTE-ACS have either nonspecific ST-segment or T-wave changes or a completely normal ECG at presentation, requiring serial troponin measurements and continued clinical observation 4, 5, 7
The European Heart Journal recommends that a 12-lead electrocardiogram (ECG) should be obtained and interpreted within 10 minutes of presentation to distinguish between STEMI and non-ST-elevation ACS (NSTE-ACS) 7, 8, 9
High-sensitivity cardiac troponin (hs-cTn) T or I with at least one value above the 99th percentile of the upper reference limit distinguishes NSTEMI from unstable angina, according to the European Heart Journal 7

Pathophysiology and Clinical Importance

The American College of Cardiology states that the underlying mechanism of ACS involves progressive lipid accumulation and inflammation within an atherosclerotic plaque leading to plaque instability, with the plaque rupture or erosion exposing the highly procoagulant contents of the atheroma core to circulating platelets and coagulation proteins, culminating in intracoronary thrombus formation 4, 5, 10
The pathophysiology of ACS is dynamic, and patients can rapidly progress from one clinical condition (unstable angina, NSTEMI, STEMI) to another during the course of their presentation and initial evaluation, underscoring the critical importance of continuous monitoring and serial assessments, as recommended by the American College of Cardiology and the Journal of the American College of Cardiology 4, 5, 6

Classification, Diagnosis, and Clinical Management of Acute Coronary Syndromes

Definitions and Pathophysiology

Acute coronary syndrome (ACS) includes three clinical entities—ST‑segment elevation myocardial infarction (STEMI), non‑ST‑segment elevation myocardial infarction (NSTEMI), and unstable angina—each sharing atherosclerotic plaque disruption with coronary thrombosis but differing in the degree of vessel occlusion and myocardial necrosis. 11
STEMI represents complete coronary artery occlusion causing transmural myocardial necrosis and requires immediate reperfusion (primary PCI within 120 minutes or fibrinolysis when PCI is unavailable) to reduce mortality. [12][11]
NSTEMI is defined by cardiac troponin concentrations above the 99th percentile without persistent ST‑segment elevation on the 12‑lead ECG. 12
Typical ECG manifestations of NSTEMI may include transient ST‑segment elevation, persistent or transient ST‑segment depression, T‑wave inversion, flat T waves, pseudo‑normalization of T waves, or a completely normal tracing. [12][13]
The clinical spectrum of NSTEMI ranges from asymptomatic presentation to ongoing ischemia, electrical or hemodynamic instability, or cardiac arrest. [12][14]
Unstable angina is characterized by myocardial ischemia at rest or with minimal exertion in the absence of cardiomyocyte necrosis (normal troponin). [12][15]
With the adoption of high‑sensitivity troponin assays, the absolute prevalence of unstable angina has fallen by 4 % (≈20 % relative), accompanied by a reciprocal rise in NSTEMI diagnoses. [12][15]
All three ACS entities correspond to Type 1 myocardial infarction under the Universal Definition, caused by plaque rupture, ulceration, erosion, or dissection with intraluminal thrombus formation. [12][11]15
Type 2 myocardial infarction denotes myocardial necrosis secondary to supply‑demand mismatch (e.g., coronary spasm, tachyarrhythmia, anemia, severe hypertension) rather than plaque instability. [12][15]
Other coronary etiologies—coronary artery spasm, embolism, or spontaneous dissection—can mimic ACS clinically but require distinct therapeutic strategies. 11

Diagnostic Pathways

An initial 12‑lead ECG obtained within 10 minutes of presentation determines the immediate management route for ACS. [12][11]
STEMI pathway: Persistent ST‑segment elevation → immediate reperfusion therapy. 12
Non‑ST‑elevation ACS pathway: Absence of persistent ST elevation → high‑sensitivity troponin testing.
- Troponin > 99th percentile with a rise/fall pattern → NSTEMI. 12
- Normal troponin → unstable angina. 12

Prognostic Implications

Patients with unstable angina have a substantially lower risk of death compared with those diagnosed with NSTEMI and derive less incremental benefit from intensified antiplatelet regimens or early invasive strategies. [12][15]

Clinical Pitfalls and Monitoring

ACS is a dynamic process; patients may progress rapidly from unstable angina to NSTEMI and then to STEMI as a partially occlusive thrombus evolves into complete occlusion. 11
A normal initial ECG does not exclude ACS: up to 41 % of NSTE‑ACS patients lack ST‑segment depression or T‑wave inversion, and 1–6 % of individuals with a completely normal ECG will ultimately be diagnosed with myocardial infarction. 14
Atypical presentations are common in women, older adults, and individuals with diabetes, who often exhibit dyspnea, nausea, generalized weakness, syncope, or epigastric discomfort and may have non‑diagnostic ECGs, necessitating heightened clinical vigilance. [14][15]
Serial assessment is mandatory: continuous ECG monitoring and repeat troponin measurements at 1–3 hours (high‑sensitivity assays) or 6–12 hours (standard assays) are essential because initial values can be normal in an evolving myocardial infarction. 12